SC 13G

Company

Aclaris Therapeutics, Inc.

Filed

February 14, 2017

Accession Number

0001019056-17-000208

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →